A phase I trial of recombinant human interleukin-1β(OCT-43) following high-dose chemotherapy and autologous bone marrow transplantation
Elkordy, M, Crump, M, Vredenburgh, J J, Petros, W P, Hussein, A, Rubin, P, Ross, M, Gilbert, C, Modlin, C, Meisenberg, BVolume:
19
Year:
1997
Language:
english
Pages:
8
DOI:
10.1038/sj.bmt.1700633
File:
PDF, 137 KB
english, 1997